资讯
Mesenchymal stem cells are multipotent adult stem cells that are present in multiple tissues, including umbilical cord, bone marrow and fat tissue. Mesenchymal stem cells can self-renew by ...
Steminent Biotherapeutics specializes in developing innovative stem cell-based therapeutics that offer new hope for patients ...
Steminent Biotherapeutics Inc. is set to present Stemchymal®, its lead investigational therapy, at the World Orphan Drug ...
Mesenchymal stem cells (MSCs) have long been recognized for their potential in cancer therapy. However, the effectiveness of MSCs in cancer treatment has been hampered by their limited tumor-homing ...
Universiti Kebangsaan Malaysia (UKM) created history when it became the first institution in the country to successfully ...
Swedish golf legend Jesper Parnevik, known for his flair and fitness, opens up about stem cell therapy, longevity, and why ...
An interim look at the results is due later this month Mesoblast has also run a phase 3 trial of its mesenchymal stem cell therapy Revascor (rexlemestrocel-L) in chronic heart failure – DREAM HF ...
At its third attempt, Mesoblast has secured FDA approval for Ryoncil as a treatment for children with graft-versus-host disease, the first-ever approval for a mesenchymal stromal cell (MSC ...
Apr. 16, 2025 — Scientists have discovered how aging blood stem cells acquire mutations that give them a growth edge, creating fertile ground for the development of clonol hematopoiesis ...
Wa'el Hashad Wa'el Hashad, CEO, Longeveron MIAMI, April 22, 2025 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ: LGVN), a ...
1 天
News-Medical.Net on MSNNetwork pharmacology analysis reveals HXTL mechanism in treating postmenopausal osteoporosisHuo Xue Tong Luo Capsule (HXTL) has been clinically used to treat osteonecrosis of the femoral head, osteoporosis, and other bone and joint diseases with promising effects.
一些您可能无法访问的结果已被隐去。
显示无法访问的结果